Clinical Trial Update: AtorvaStatin Postpartum and Reduction of Cardiovascular risK [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating AtorvaStatin for postpartum cardiovascular risk reduction in women with hypertensive disorders of pregnancy, including pree…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Hypertension
• Hypertensive Disorders of Pregnancy
• Preeclampsia

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Ohio State University | Conditions: Hypertensive Disorders of Pregnancy, Preeclampsia | Phase 4 | Status: RECRUITING